General Infectious
Disease Learning Objectives
Author: Andrew
Kitcher
Editor: Lauren Peccoralo, MD
Educational Rationale
A majority of the
patients admitted to the general medical service, the specialty services
including A4, Popper and Wasserman, and to the MICU have infection either on
presentation or as a complication of their primary presenting disease.
General internists should be very familiar with the most common infections seen
at the hospital, as well as able to recognize a wide variety of illnesses based
on clinical presentation, the physical exam, laboratory and imaging studies.
I. General Learning Objectives
By the end of a
three-year residency in Internal Medicine, all housestaff should be able to:
A. Clinical Skills:
1. Take a detailed history and perform a physical
exam with focus on infectious diseases
2. Ask about specific infectious signs, including
fever, chills, weight loss, productive cough, diarrhea, urinary symptoms, skin
changes and meningeal signs.
3. Take a
detailed sexual and social history, and ask about other risks, such as travel
and sick contacts.
4. Examine the oropharynx, perform meningeal
maneuvers, palpate lymphadenopathy and characterize skin lesions.
B. Interpersonal Skills
1. Relay
information to consultants regarding risks and baseline immunological status.
2. Always relaying the latest CD4 count and viral load in
HIV + patients
3. Knowing
the hospital course, antibiotic and immunosuppresive history, as well as
infectious signs and fever curve of
a patient when consulting an infectious disease specialist.
4.
Keep documented record in
signouts, daily notes and discharge/transfer summaries
the antibiotic history, fever and WBC curve, and clinical course of a
hospitalized patient.
C. Procedural Skills
1. Perform
a lumbar puncture on uncomplicated patients with normal anatomy:
http://content.nejm.org/cgi/video/355/13/e12/
*Intern Focused Topics
II. Medical Knowledge Learning Objectives
By the end of a three-year residency in Internal Medicine, all housestaff
should be able to:
A. *Pneumonia
1. Recognize
pneumonia on a chest Xray.
2. Describe the most comon organisms causing
pneumonia in adults, the elderly, and in at-risk groups such as HIV patients
and ventilated patients.
3. Understand the difference between CAP, HCAP,
HAP and VAPs, and initiate treatment based on the likely pathogens.
4. Readings:
a. Associations
between initial antimicrobial therapy and medical outcomes for
hospitalized elderly patients with pneumonia. Arch Intern Med 159:2562-72
1999.
http://eresources.library.mssm.edu:2217/cgi/content/full/159/21/2562
b. A prediction rule to identify low-risk patients with
community-acquired
pneumonia. N Engl J Med 336:243-50 1997.
http://eresources.library.mssm.edu:2368/cgi/content/abstract/336/4/243
c. Halm, Teirstein. Management of
Community-Acquired Pneumonia. NEJM
347: 2039-2045, 2002
http://eresources.library.mssm.edu:2368/cgi/content/extract/347/25/2039
d. Scheduled change of antibiotic classes: a strategy to
decrease the incidence of
ventilator-associated pneumonia. Am J Respir Crit Care Med 156:1040-8 1997.
http://eresources.library.mssm.edu:2192/cgi/content/full/156/4/1040
B. *Sepsis/SIRS
1. Characterize a patient as SIRS/sepsis/severe
sepsis/septic shock based on the
DREAM protocol
2. Initiate treatment with appropriate fluid
resuscitation, antibiotics, steroids and
pressors as needed, depending on the clinical situation.
3. Know which markers to follow to determine clinical
improvement or deterioration.
4. Readings:
a. APACHE II: a severity of disease
classification system. Crit Care Med
13:818-29 1985.
http://eresources.library.mssm.edu:8537/spa/ovidweb.cgi?WebLinkFrameset=1&S=ANFFFPLBFCDDIMJENCFLPCPJFLPMAA00&returnUrl=http%3a%2f%2fovidsp.tx.ovid.com%2fspa%2fovidweb.cgi%3fMain%2bSearch%2bPage%3d1%26S%3dANFFFPLBFCDDIMJENCFLPCPJFLPMAA00&directlink=http%3a%2f%2fgraphics.tx.ovid.com%2fovftpdfs%2fFPDDNCPJPCJEFC00%2ffs046%2fovft%2flive%2fgv023%2f00003246%2f00003246-198510000-00009.pdf&filename=APACHE+II%3a+A+severity+of+disease+classification+system.
b. Early goal-directed therapy in the treatment of severe
sepsis and septic shock.
N Engl J Med 345:1368-77 2001.
http://eresources.library.mssm.edu:2368/cgi/content/abstract/345/19/1368
c. A multicenter, randomized, controlled clinical
trial of transfusion
requirements in critical care. Transfusion Requirements in Critical
Care Investigators, Canadian Critical Care Trials Group. N Engl J Med
340:409-17 1999.
http://eresources.library.mssm.edu:2368/cgi/content/abstract/340/6/409
d. Effect of treatment with low doses of
hydrocortisone and fludrocortisone on
mortality in patients with septic shock. JAMA
288:862-71 2002.
http://eresources.library.mssm.edu:2213/cgi/content/full/288/7/862
e. Efficacy and safety of recombinant human
activated protein C for severe
sepsis. N Engl J Med 344:699-709 2001.
http://eresources.library.mssm.edu:2368/cgi/content/abstract/344/10/699
C. *Osteomyelitis
1. Recognize risk factors and the physical
findings concerning for osteomyelitis, as well
as the radiographic studies to order.
2. Treat osteomyelitis with extended antibiotic
courses depending on risk factors and
isolates.
3. Readings:
a. Kapoor, A, Page, S, Lavalley, M, et al.
Magnetic resonance imaging for
diagnosing foot osteomyelitis: a meta-analysis. Arch Intern Med 2007;
167:125.
http://eresources.library.mssm.edu:2217/cgi/content/full/167/2/125
b. Gentry, LO, Rodriguez-Gomez, G, Ofloxacin
versus parenteral therapy for
chronic osteomielitis. Antimicrob Agents Chemother
1991; 35:538.
http://eresources.library.mssm.edu:2200/cgi/reprint/35/3/538?view=long&p mid=2039205
c. Chen, CE, Ko, JY, Fu, TH, Wang, CJ. Results of
chronic osteomyelitis of the
femur treated with hyperbaric oxygen: a preliminary report. Chang Gung
Med J2004; 27:91.
D. *Line Infections
1. Identify signs and symptoms of line infections
2. Know the indications for line removal and
replacement, the likely organisms, and the
indications for TEE.
3. Readings:
a. Durack, DT, Lukes, AS, Bright, DK. New
criteria for diagnosis of infective
endocarditis: utilization of specific echocardiographic findings. Duke
Endocarditis Service. Am J Med 1994; 96:200. http://eresources.library.mssm.edu:2968/?sid=Entrez:PubMed&id=pmid:8154507
b. Shively, BK, Gurule, FT, Roldan, CA, et al.
Diagnostic value of
transesophageal compared with transthoracic echocardiography in
infective endocarditis. J Am Coll Cardiol 1991; 18:391.
http://eresources.library.mssm.edu:2968/?sid=Entrez:PubMed&id=pmid:1856406
c. Petti, CA, Bhally, HS, Weinstein, MP, et al.
Utility of extended blood culture
incubation for isolation of haemophilus, actinobacillus,
cardiobacterium, eikenella, and kingella organisms: a retrospective multicenter
evaluation. J Clin Microbiol 2006; 44:257
http://eresources.library.mssm.edu:2204/cgi/content/full/44/1/257?view=long&pmid=16390985
E. *C. Difficile
1. Recognize the signs/symptoms of C. diff and
the risk factors for infection.
2. Discussthe utility of C. difficile antigen
testing, the definition of treatment failure or "
resistant C. diff.
3. Treat resistant C. diff
4. Readings:
a. Pepin, J, Saheb, N, Coulombe, MA, et al.
Emergence of fluoroquinolones as
the predominant risk factor for Clostridium difficile-associated
diarrhea: a cohort study during an epidemic in Quebec. Clin Infect
Dis 2005; 41:1254
http://eresources.library.mssm.edu:2284/doi/abs/10.1086/496986
b. Dial, S, Delaney, JA, Barkun, AN, Suissa, S.
Use of gastric acid-suppressive
agents and the risk of community-acquired Clostridium
difficile-associated disease. JAMA 2005; 294:2989.
http://eresources.library.mssm.edu:2213/cgi/content/full/294/23/2989
c. Bettin, K, Clabots, C, Mathie, P, et al.
Effectiveness of liquid soap vs.
chlorhexidine gluconate for the removal of Clostridium difficile from
bare hands and gloved hands. Infect Control Hosp Epidemiol 1994; 15:697.
http://eresources.library.mssm.edu:2968/?sid=Entrez:PubMed&id=pmid:7852725
d. Zar, FA, Bakkanagari, SR, Moorthi, KM, Davis,
MB. A comparison of
vancomycin and metronidazole for the treatment of Clostridium
difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis
2007; 45:302.
F. *Urinary tract infections
1. Recognize the signs, symptoms and risk factors
for urinary tract infections, inside and
outside the hospital
2. Distinguish between an uncomplicated urinary tract
infection, pyelonephritis and
urosepsis, and manage the treatment of each.
3. Readings:
a. Jain, P, Parada, JP, David, A, et al. Overuse of the
indwelling urinary tract
catheter in hospitalized medical patients. Arch Intern
Med 1995; 155:1425
http://eresources.library.mssm.edu:2217/cgi/reprint/155/13/1425
b. Hooton, TM, Stamm, WE. Diagnosis and treatment of
uncomplicated urinary
tract infection. Infect Dis Clin North Am 1997;
11:551.
http://eresources.library.mssm.edu:2125/das/article/body/143725865- 2/jorg=journal&source=&sp=9917659&sid=0/N/84667/1.html?issn=0891-5520
d. Johnson, JR, Kuskowski, MA, Wilt, TJ.
Systematic review: antimicrobial
urinary catheters to prevent catheter-associated urinary tract
infection in hospitalized patients. Ann Intern Med 2006; 144:116.
http://eresources.library.mssm.edu:2308/pqdweb?index=0&did=974775981&SrchMode=1&sid=1&Fmt=4&VInst=PROD&VType=PQD&RQT=309&VName=PQD&TS=1245179147&clientId=15325
G. Bacterial Meningitis
1. *Recognize the signs, symptoms and risk factors
for bacterial meningitis.
2. *Perform a physical exam with emphasis on
meningeal signs.
3. Be able to perform a lumbar puncture (and ideally an eye exam
prior to LP) for
emergent management of meningitis.
4. Distinguish between LP profiles and initiate emergent
treatment for bacterial
meningitis.
5. Readings:
a. Van de Beek D, de Gans J, Tunkel AR, Wijdicks
EF. Community-acquired
bacterial meningitis in adults. N Engl J Med.
2006 Jan 5;354(1):44-53
http://eresources.library.mssm.edu:2368/cgi/content/extract/354/1/44
b. Scarborough, M, Gordon, SB, Whitty, CJ, et al.
Corticosteroids for bacterial
meningitis in adults in Sub-Saharan Africa. N Engl J
Med 2007; 357:2441.
http://eresources.library.mssm.edu:2368/cgi/content/abstract/357/24/2441
c. de Gans, J, van de Beek, D. Dexamethasone in adults
with bacterial
meningitis. N Engl J Med 2002; 347:1549.
http://eresources.library.mssm.edu:2368/cgi/content/abstract/347/20/1549
d. van de Beek, D, de Gans, J, Spanjaard, L, et al.
Clinical features and
prognostic factors in adults with bacterial
meningitis. N Engl J Med 2004;
351:1849
http://eresources.library.mssm.edu:2368/cgi/content/abstract/351/18/1849
H. Tuberculosis
1. *Recognize signs, symptoms, and risk factors
for active and latent tuberculosis.
2. *Interpret a PPD, and initiate screening and
treatment.
3. Know the variants of triple therapy, and the
side effects of treatment.
4. Recognize signs and symptoms for extrapulmonary TB.
5. Readings:
a. Van den Brande, PM, Van de Mierop, T, Verben,
K, Demedts, M. Clinical
spectrum of endobronchial tuberculosis in elderly
patients. Arch Intern Med
1990; 150:2105.
http://eresources.library.mssm.edu:2217/cgi/reprint/150/10/2105
b. Marciniuk, DD, McNab, BD, Martin, WT, Hoeppner, VH.
Detection of
pulmonary tuberculosis in patients with a normal chest
radiograph. Chest
1999; 115:445.
http://eresources.library.mssm.edu:2277/content/115/2/445.long
c. MK.Leonard Jr., E Kourbatova, HM. Blumberg .How many sputum
specimens are necessary to diagnose pulmonary
tuberculosis? American
Journal of Infection Control, Volume 34, Issue 5, June 2006, Pages
328-329.
http://eresources.library.mssm.edu:2080/science?_ob=ArticleURL&_udi=B6W9M-4FC3626-J&_user=30742&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000000333&_version=1&_urlVersion=0&_userid=30742&md5=05bef8f03392023d2f688ba3f409dc4b
e. Small, PM, Fujiwara, PI. Management of
tuberculosis in the United States. N Engl J Med 2001; 345:189.
http://eresources.library.mssm.edu:2368/cgi/content/extract/345/3/189
f. Chang, KC, Leung, CC, Yew, WW, et al. Dosing
schedules of 6-month
regimens and relapse for pulmonary tuberculosis. Am J Respir Crit Care Med 2006; 174:1153.
http://eresources.library.mssm.edu:2192/cgi/content/full/174/10/1153
g. Weis, SE, Slocum, PC, Blais, FX, et al. The
effect of directly observed
therapy on the rates of drug resistance and relapse in
tuberculosis. N Engl J
Med 1994; 330:1179.
http://eresources.library.mssm.edu:2368/cgi/content/abstract/330/17/1179
I. *STDS
1. Distinguish between genitourinary lesions based on history
and physical exam.
2. Recognize complications of sexually
transmitted disease, including Reiter's
syndrome, secondary and tertiary syphilis, and
gonococcal arthritis.
3. Initiate the different antibiotic treatments
and the lengths of treatment for gonorrhea,
syphilis, chlamydia, genital warts and pubic
parasites.
4. Discuss risk factors for blood-borne and
sexually transmitted diseases, including
blood products, sexual transmission, shared needles
and cocaine straw use.
5. Readings:
a. Sherrard, J et al. Gonorrhoea in men:
Clinical and diagnostic aspects.
Genitouin Med 1996; 72:422. http://eresources.library.mssm.edu:2152/articlerender.fcgi?tool=pubmed&pubmedid=9038638
b. Workowski, KA, Berman, SM. Sexually
transmitted diseases treatment
guidelines, 2006. MMWR Recommn Rep 2006; 55:1. http://eresources.library.mssm.edu:2309/mmwr/preview/mmwrhtml/rr5511a1.htm
c. Rice, PA. Gonococcal arthritis
(desseminated gonococcal infection). Infect
Dis Clin North Am 2005; 19:853. http://eresources.library.mssm.edu:2080/science?_ob=ArticleURL&_udi=B75J9-4HK6YR4-9&_user=30742&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000000333&_version=1&_urlVersion=0&_userid=30742&md5=f8706549126288e5f97ad7fc66a255d3
d. Hook, EW II, Marra, CM. Acquired syphilis in
adults. NEJM 1992;326:1060.
http://eresources.library.mssm.edu:2968/?sid=Entrez:PubMed&id=pmid:1549153
e.
Rihl et. al.
Infection and musculoskeletal conditions: Reactive arthritis. Bes
Pract Res Clin Rheumatol 2006; 20:1119. http://eresources.library.mssm.edu:2080/science?_ob=ArticleURL&_udi=B6WBJ-4MDP7DT-8&_user=30742&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000000333&_version=1&_urlVersion=0&_userid=30742&md5=d63e7d8a57cb800da2209cbaf48e066e
f. Laasila
et. al. Antibiotic treatment and long-term prognosis of reactive
arthritis. Ann Rheum Dis 2003; 62:655.
http://eresources.library.mssm.edu:7026/cgi/content/full/62/7/655
g. Kimberlin DW, Rouse DJ. Clinical
practice. Genital herpes. N Engl J Med.
2004 May 6;350(19):1970-7.
http://eresources.library.mssm.edu:2368/cgi/content/extract/350/19/1970
h. Pathogen safety of plasma-derived
products. Haemophilia. 2008 Nov;14
Suppl 5:54-71 http://eresources.library.mssm.edu:2968/?sid=Entrez:PubMed&id=pmid:18786011
i. Burnouf, T. Modern plasma
fractionation. Transfusion Med Rev 2007.
j. Estrada, AL. Epidemiology of HIV/AIDS,
hepatitis B, hepatitis C, and
tuberculosis among minority injection drug users. Public Health
Rep. 2002;117 Suppl 1:S126-34 http://eresources.library.mssm.edu:2152/articlerender.fcgi?tool=pubmed&pubmedid=12435836
k. Macias et. al. High prevalence of
hepatitis C virus infection among
noninjecting drug users: association with sharing the inhalation
implements of crack. Liver Int. 2008 Jul;28(6):781-6.
http://eresources.library.mssm.edu:2097/journal/120091233/abstract
J. *Vaccines
1. Discuss with patients the utility and
indications of the influenza vaccine, including
distinguishing the subtypes of influenza targeted
annually, and the antiviral
medications covering the subtypes.
2. Discuss with patients the efficacy and indications of
pnuemococcal vaccination.
3. Discuss with patients the indications and efficacy of
HPV vaccination
4. Readings:
a. Effectiveness of pneumococcal polysaccharide
vaccine in older adults. N
Engl J Med 348:1747-55 2003
http://eresources.library.mssm.edu:2368/cgi/content/abstract/348/18/1747
b. Glezen WP. Clinical practice. Prevention and
treatment of seasonal
influenza. N Engl J Med. 2008 Dec
11;359(24):2579-85.
http://eresources.library.mssm.edu:2368/cgi/content/extract/359/24/2579
d. Szmuness, W, Stevens, CE, Harley, EJ, et al.
Hepatitis B vaccine:
Demonstration of efficacy in a controlled clinical trial in a high-risk
population in the United States. N Engl J Med 1980; 303:833.
http://eresources.library.mssm.edu:2968/?sid=Entrez:PubMed&id=pmid:6997738
e. Lok, AS, McMahon, BJ. Chronic hepatitis B:
update of recommendations.
Hepatology 2004; 39:857.
http://eresources.library.mssm.edu:2097/journal/107630495/abstract
f. Cardell,
K, Akerlind, B, Sallberg, M, Fryden, A. Excellent response rate to a
double dose of the combined hepatitis A and B vaccine
in previous
nonresponders to hepatitis B vaccine. J Infect Dis 2008; 198:299.
http://eresources.library.mssm.edu:2284/doi/abs/10.1086/589722?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dncbi.nlm.nih.gov
g. Quadrivalent vaccine against human papillomavirus to
prevent high-grade
cervical lesions. N Engl J Med 2007; 356:1915.
http://eresources.library.mssm.edu:2368/cgi/content/abstract/356/19/1915
h. Ault, KA. Effect of prophylactic human
papillomavirus L1 virus-like-particle
vaccine on risk of cervical intraepithelial neoplasia
grade 2, grade 3, and
adenocarcinoma in situ: a combined analysis of four
randomised clinical
trials. Lancet 2007; 369:1861.
http://eresources.library.mssm.edu:2080/science?_ob=ArticleURL&_udi=B6T1B-4NVVDHV-12&_user=30742&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000000333&_version=1&_urlVersion=0&_userid=30742&md5=db1495df8b75b2b4f791bc601e1cb45d
K. Travel Medicine
1. *Recognize the key features of bloody and
non-bloody diarrheal illnesses, and intiate
treatment of each.
2. Recognize the characteristic rashes of rickettsial
diseases, Lyme, etc, and initiate
antibiotic therapy.
3. Recognize the different types of gatrointestinal and
extra-gastrointestinal parasitic
diseases, and the characteristic ova and parasite
stool findings.
4. Recognize the classic fever curve of the different
malarial illnesses, their findings on
blood smear, and the pattern of disease in hypnozooite-mediated
disase.
5. Readings:
a. Clinical practice: Acute infectious diarrhea.
N Engl J Med 350:38-47 2004
http://eresources.library.mssm.edu:2368/cgi/content/extract/350/1/38
b. Musher DM, Musher BL. Contagious acute
gastrointestinal infections. N
Engl J Med. 2004 Dec 2;351(23):2417-27.
http://eresources.library.mssm.edu:2368/cgi/content/extract/351/23/2417
c. Steere AC. Lyme disease. N Engl J
Med. 2001 Jul 12;345(2):115-25.
http://eresources.library.mssm.edu:2368/cgi/content/extract/345/2/115
d. Spach DH, Liles WC, Campbell GL, Quick RE, Anderson DE
Jr, Fritsche
TR. Tick-borne diseases in the United
States. N Engl J Med. 1993 Sep
23;329(13):936-47.
http://eresources.library.mssm.edu:2368/cgi/content/extract/329/13/936
e. Navin TR, Juranek DD. Cryptosporidiosis:
clinical, epidemiologic, and
parasitologic review. Rev Infect Dis. 1984 May-Jun;6(3):313-27.
http://eresources.library.mssm.edu:2968/?sid=Entrez:PubMed&id=pmid:6377439
f. Haque R, Huston CD, Hughes M, Houpt E, Petri
WA Jr. Amebiasis. N Engl
J Med. 2003 Apr 17;348(16):1565-73 http://eresources.library.mssm.edu:2368/cgi/content/extract/348/16/1565
g. Ross AG, Bartley PB, Sleigh AC, Olds GR, Li Y,
Williams GM, McManus DP. Schistosomiasis. N Engl J Med. 2002 Apr
18;346(16):1212-20.
http://eresources.library.mssm.edu:2368/cgi/content/extract/346/16/1212
h. Liu LX, Weller PF. Antiparasitic
drugs. N Engl J Med. 1996 May 2;334(18):1178-84.
http://eresources.library.mssm.edu:2368/cgi/content/extract/334/18/1178
i. White NJ. The treatment of malaria. N Engl
J Med. 1996 Sep 12;335:800.
http://eresources.library.mssm.edu:2368/cgi/content/extract/335/11/800
j. Krogstad DJ, Schlesinger PH. Acid-vesicle
function, intracellular pathogens,
and the action of chloroquine against Plasmodium falciparum. N
Engl J Med. 1987 Aug 27;317(9):542-9.
http://eresources.library.mssm.edu:2968/?sid=Entrez:PubMed&id=pmid:3302712
k. Imwong M et al. Relapses of Plasmodium
vivax infection usually result from activation of heterologous
hypnozoites. J Infect Dis. 2007 Apr 1;195(7):927-33. Epub 2007 Feb 26.
http://eresources.library.mssm.edu:2284/doi/abs/10.1086/512241?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dncbi.nlm.nih.gov
L.
Post-transplant Medicine
1. Recognize viral, bacterial, fungal and
parasitic infections in post-transplant patients.
2. Initiate therapy for common post-transplant
infections.
3. Readings:
a. Fishman, JA. Infection in solid-organ
transplant recipients. N Engl J Med
2007; 357:2601. http://eresources.library.mssm.edu:2368/cgi/content/extract/357/25/2601
b. Winston, DJ, Emmanouilides, C, Busuttil, RW.
Infection in liver transplant recipients. Clin Infect Dis 1995; 21:1077.
http://eresources.library.mssm.edu:2968/?sid=Entrez:PubMed&id=pmid:8589125
c. Singh, N, Paterson, DL. Mycobacterium
tuberculosis infection in solid- organ transplant recipients: Impact and
implications for management. Clin Infect Dis 1998; 27:1266. http://eresources.library.mssm.edu:2968/?sid=Entrez:PubMed&id=pmid:9827281
d. Aguado, JM, Herrero, JA, Gavalda, J, et al.
Clinical presentation and outcome of tuberculosis in kidney, liver, and heart
transplant recipients in Spain. Transplantation 1997; 63:1278.
http://journals.lww.com/transplantjournal/pages/articleviewer.aspx?year=1997&issue=05150&article=00015&type=abstract
e. Infectious Disease Community of Practice,
Amercian Society of Transplantation, Infectious Disease Guidelines for
Transplantation. Am J Transpl 2004; 4 (Suppl 10):5.
http://eresources.library.mssm.edu:2968/?sid=Entrez:PubMed&id=pmid:11777100
http://asheducationbook.hematologylibrary.org/cgi/content/full/2001/1/392
f. Fishman, JA. Pneumocystis carinii and
parasitic infections in transplantation. Infect Dis ClinNorth Am 1995; 9:1005.
http://eresources.library.mssm.edu:2968/?sid=Entrez:PubMed&id=pmid:8747777
g. Paya, CV. Fungal infections in solid organ
transplantation. Clin Infect Dis 1993; 16:677.
http://eresources.library.mssm.edu:2968/?sid=Entrez:PubMed&id=pmid:8507760
h. Gardner, SD, MacKenzie, EF, Smith, C, Porter,
AA. Prospective study of the human polyomaviruses BK and JC and cytomegalovirus
in renal transplant recipients. J Clin Pathol 1984; 37:578.
http://eresources.library.mssm.edu:7015/cgi/reprint/37/5/578
i. Eid, AJ, Brown, RA, Patel, R, Razonable, RR.
Parvovirus B19 infection after
transplantation: a review of 98 cases. Clin Infect Dis
2006; 43:40.
i. Falagas, M, Snydman, D, George, M, et al.
Incidence and predictors of
cytomegalovirus pneumonia in orthotopic liver transplant recipients.
Transplantation 1996; 61:1716.
http://eresources.library.mssm.edu:2968/?sid=Entrez:PubMed&id=pmid:9332531
Note for hyperlinks:
several of the older articles are not available online; the hyperlink leads to
the MSSM library catalogue entry.